Literature DB >> 3549325

Miglitol may have a blood glucose lowering effect unrelated to inhibition of alpha-glucosidase.

P H Joubert, G N Foukaridis, M L Bopape.   

Abstract

Miglitol is an alpha-glucosidase inhibitor which lowers blood glucose and insulin concentrations in healthy volunteers after a starch meal. It also lowers blood glucose concentrations after a starch meal in patients with non-insulin-dependent diabetes mellitus, but under these circumstances insulin is unaffected. We have studied the effect of miglitol after a glucose load in six healthy male volunteers. Although one would expect an alpha-glucosidase inhibitor to have no effect on blood glucose concentrations after a glucose load, miglitol produced a significant decrease in blood glucose concentrations after the absorption peak. This could be due to enhancement of insulin effects or to depression of anti-insulin factors.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3549325     DOI: 10.1007/BF00541303

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  3 in total

1.  [Glucosidase inhibitors from Bacilli].

Authors:  D D Schmidt; W Frommer; L Müller; E Truscheit
Journal:  Naturwissenschaften       Date:  1979-11

2.  Effects of the alpha-glucosidase inhibitor 1 desoxynojirimycin (Bay m 1099) on postprandial blood glucose, serum insulin and C-peptide levels in type II diabetic patients.

Authors:  C Schnack; G Röggla; A Luger; G Schernthaner
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

3.  The effect of a 1-deoxynojirimycin derivative on post-prandial blood glucose and insulin levels in healthy black and white volunteers.

Authors:  P H Joubert; C P Venter; H F Joubert; I Hillebrand
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

  3 in total
  7 in total

Review 1.  Miglitol: a review of its therapeutic potential in type 2 diabetes mellitus.

Authors:  L J Scott; C M Spencer
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546

2.  The effect of miglitol and acarbose after an oral glucose load: a novel hypoglycaemic mechanism?

Authors:  P H Joubert; H L Venter; G N Foukaridis
Journal:  Br J Clin Pharmacol       Date:  1990-09       Impact factor: 4.335

3.  Reduction of postprandial blood glucose by the alpha-glucosidase inhibitor Miglitol (BAY m 1099) in type II diabetes.

Authors:  G Heinz; M Komjati; A Korn; W Waldhäusl
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

4.  A novel library of -arylketones as potential inhibitors of α-glucosidase: Their design, synthesis, in vitro and in vivo studies.

Authors:  Tania Luthra; Rahul Agarwal; Mamidala Estari; Uma Adepally; Subhabrata Sen
Journal:  Sci Rep       Date:  2017-10-16       Impact factor: 4.379

5.  Iminosugars Spiro-Linked with Morpholine-Fused 1,2,3-Triazole: Synthesis, Conformational Analysis, Glycosidase Inhibitory Activity, Antifungal Assay, and Docking Studies.

Authors:  Shrawan R Chavan; Kishor S Gavale; Ayesha Khan; Rakesh Joshi; Navanath Kumbhar; Debamitra Chakravarty; Dilip D Dhavale
Journal:  ACS Omega       Date:  2017-10-26

6.  Exploiting angled thin film vortex microfluidics for expeditious syntheses of iminosugars.

Authors:  Jeremy Duczynski; Colin L Raston; Keith A Stubbs
Journal:  RSC Adv       Date:  2022-08-17       Impact factor: 4.036

Review 7.  Carbohydrate-based drugs launched during 2000-2021.

Authors:  Xin Cao; Xiaojing Du; Heng Jiao; Quanlin An; Ruoxue Chen; Pengfei Fang; Jing Wang; Biao Yu
Journal:  Acta Pharm Sin B       Date:  2022-05-23       Impact factor: 14.903

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.